News | June 01, 2008

Abiomed Receives 510(k) Clearance from FDA for Impella 2.5

June 2, 2008 - Abiomed Inc. received 510(k) clearance from FDA for Impella 2.5 Device Cardiac Assist Device, allowing Abiomed to sell the device in the U.S.

The Impella 2.5 is cleared for use under the 510(k) for partial circulatory support for periods up to six hours. The intra-aortic balloon pump (IABP) also has 510(k) clearance and approximately 110,000 are used each year in the United States. Abiomed is currently conducting two U.S. pivotal studies comparing the Impella 2.5 to the IABP.

The Impella 2.5 is inserted percutaneously in the catheterization laboratory via the femoral artery into the left ventricle. Up to 2.5 liters of blood per minute are delivered by the pump from the left ventricle into the ascending aorta, providing the heart with active support in critical situations.

"FDA clearance of the Abiomed Impella 2.5 represents the next step in enabling heart recovery for patients in the U.S. and will likely change the standard of care in the catheterization lab," said Abiomed Chairman, CEO and President Michael R. Minogue. "The device seamlessly provides immediate, minimally invasive circulatory support for critical patients."

The Impella 2.5 is now approved in more than 40 countries, including in Europe for up to seven days of support under the CE Mark.

For more information: www.abiomed.com

Related Content

IABP recall for Maquet, Datascope intra-aortic balloon pump CS100 and CS300

The Datascope CS300 IABP console.

News | Hemodynamic Support Devices| June 20, 2017
June 20, 2017 — The U.S.
Technology | Intra-Aortic Balloon Pumps (IABP)| May 02, 2017
May 2, 2017 — The U.S. Food and Drug Administration (FDA) granted 510(k) clearance for the Teleflex Inc.
Impella CP heart pump, TCT 2016, intra-aortic balloon counterpulsation, IABP, clinical study
News | Intra-Aortic Balloon Pumps (IABP)| January 03, 2017 | Dave Fornell
The Impella CP heart pump (Abiomed) demonstrated no improvement in mortality for patients with myocardial infarction...
Teleflex, Arrow IAB catheter, intra-aortic balloon pump, worldwide recall
News | Intra-Aortic Balloon Pumps (IABP)| March 11, 2016
Teleflex Inc. announced the worldwide recall of Arrow International intra-aortic balloon catheter kits and percutaneous...
IABP
Sponsored Content | Webinar | Intra-Aortic Balloon Pumps (IABP)| December 22, 2015
The webinar "Hemodynamics of Counterpulsation" explained how the intra-aortic balloon pump (IABP) can increase diasto
IABP, peer review, Maquet, Journal of Invasive Cardiology
Feature | June 01, 2015
Maquet Getinge Group announced the publication of a manuscript describing the exploration of the hemodynamic effects of...
intraaortic balloon pumps, IABP, ventricular assist devices, VAD, cost effective
News | April 09, 2015
Maquet Cardiovascular USA announced publication of a manuscript comparing the clinical and economic impact of...
IABP, Datascope, Maquet, FDA recall
Feature | May 12, 2014
Datascope Corp./Maquet initiated a voluntary worldwide field correction of some of its intra-aortic balloon pumps (...
PVAD, percutaneous VAD, hemodynamic support, aortix

Procyrion Aortix is a catheter-deployed pVAD intended for long-term use in the treatment of chronic heart failure.

Feature | March 18, 2014 | Dave Fornell
Percutaneous ventricular assist (pVAD) devices offer more hemodynamic support than the 40-year-old gold standard of ...
News | October 01, 2013
Sunshine Heart Inc. has launched a website dedicated to providing information to patients suffering from moderate to...
Overlay Init